Where Are the New Cough Treatments: A Debriefing of Recent Clinical Proof-of-Concept Trials with the NOP Agonist SCH 486757

Publisher： Karger

E-ISSN： 1423-0313|88|1-2|50-54

ISSN： 0031-7012

Source： Pharmacology, Vol.88, Iss.1-2, 2011-07, pp. : 50-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of a Novel NOP Receptor Agonist (SCH 225288) on Guinea Pig Irritant-Evoked, Feline Mechanically Induced and Canine Infectious Tracheobronchitis Cough

By  

Pharmacology, Vol. 84, Iss. 3, 2009-08 ,pp. : 153-161

Karger

Access to resources Recommend Favorite

Use of Mixed Micelles for Presentation of Building Blocks in a New Combinatorial Discovery Methodology: Proof-of-Concept Studies

By New Roger   Bansal Gurpal S.   Bogus Michael   Zajkowska Kasia   Rickelt Steffen   Toth Istvan  

Molecules, Vol. 18, Iss. 3, 2013-03 ,pp. : 3427-3441

MDPI

Access to resources Recommend Favorite

188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept

By Chang Chia-Ming   Lan Keng-Li   Huang Wen-Sheng   Lee Yi-Jang   Lee Te-Wei   Chang Chih-Hsien   Chuang Chi-Mu  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-04 ,pp. : 903-903

MDPI

Access to resources Recommend Favorite

Antitussive Profile of the NOP Agonist Ro-64-6198 in the Guinea Pig

By  

Pharmacology, Vol. 71, Iss. 3, 2004-06 ,pp. : 143-149

Karger

Access to resources Recommend Favorite

New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials†

By Jimeno J.   Faircloth G.   Sousa-Faro JM Fernández   Scheuer P.   Rinehart K.  

Marine Drugs, Vol. 2, Iss. 1, 2004-02 ,pp. : 14-29

MDPI

Access to resources Recommend Favorite